Status:
UNKNOWN
Aalgesic Efficacy of Erector -Spinae Technique With Levobupvicaine in Patients Undergoing Upper Abdominal Cancer Surgery
Lead Sponsor:
South Egypt Cancer Institute
Conditions:
Erector Spinae Block Analgesia
Eligibility:
All Genders
18-70 years
Phase:
PHASE1
Brief Summary
To study analgesic efficacy \&safety of bilateral erector spinae block for upper abdominal cancer surgery as apart of multimodal analgesia.
Detailed Description
Patients will be randomly assigned using computer generated randomization program (http://www.randomizer.org) into two groups, each group of the them consist of 15 patients: GROUP (A): {CONTROL GROUP...
Eligibility Criteria
Inclusion
- Patient subjected to major upper abdominal cancer surgery.
- The enrolled age will be from 18-70 years old.
- ASA: I-III, NYHA: I-III.
Exclusion
- ASA \& physical status (NYHA) \> III.
- Pregnant women.
- Body mass index \>40 kg/m2.
- Pre-operative opioid consumption.
- Contraindication or patient's refusal of the procedure.
- Un co-operative patient.
- Coagulopathy, skin infection, significant organ dysfunction or drug allergy.
Key Trial Info
Start Date :
June 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2021
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04315454
Start Date
June 1 2019
End Date
April 1 2021
Last Update
March 19 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
South Egypt Cancer Institute
Asyut, Egypt, 171516